Skip to main content

Table 3 Distribution of patients with OPMLs in the tongue (T patients) or in all the other oral mucosal subsites (O patients) or in Buccal Mucosa (BM patients) with respect to DNA diploid or aneuploid status and to dysplastic or non-dysplastic status.

From: Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue

   Dysplastic
+
Non-dysplastic OPMLs 		 
  O patients vs. T patients (OR = 5.2; p = 0.003)*  
   T patients vs. BM patients (OR = 5.9; p = 0.002)§
  O patients T patients BM patients
DNA diploid 71 10 54
DNA aneuploid 15 (17%) 11 (52%) 10 (16%)
Total 86 21 64
   Non-dysplastic OPMLs  
  O patients vs. T patients (OR = 3.6; p = 0.07)  
   T patients vs. BM patients (OR = 3.6; p = 0.069)
  O patients T patients BM patients
DNA diploid 65 9 48
DNA aneuploid 12 (16%) 6 (40%) 9 (16%)
Total 77 15 57
   Dysplastic OPMLs  
  O patients vs. T patients (OR = 10; p = 0.12)  
   T patients vs. BM patients (OR = 36; p = 0.029)
  O patients T patients BM patients
DNA diploid 6 1 6
DNA aneuploid 3 (33%) 5 (83%) 1 (14%)
Total 9 6 7
  1. *Once stratified for presence/absence of dysplasia in the corresponding OPMLs, ORM-H = 4.5 (p = 0.005).
  2. § Once stratified for presence/absence of dysplasia in the corresponding OPMLs, ORM-H = 5.2 (p = 0.003).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us